Japan· JP-1149401A2023
ペンタゾシン
A pentazocine product containing ペンタゾシン, registered in Japan by 丸石製薬, on the national reimbursement list. The same ATC class is registered in 5 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Pentazocine is registered in 5 of 19 countries.
Countries holding a registration under ATC N02AD01 (pentazocine), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 3 of them publish a price we can compare per daily dose
Pentazocine · ATC N02AD01
5 / 19 countries
- Belgiumprice
- Finlandprice
- Japan
- Norwayprice
- United Kingdom
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- ペンタゾシン
- Manufacturer
- 丸石製薬
- Country
- Japan (JP)
- ATC code
- N02AD01
- ATC class
- Pentazocine
- Defined daily dose
- 0.2 g, O
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
136 interactions on record for pentazocine.
Graded by severity as the source publishes them — 27 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Pentazocine · interactions on record
136 records
- 27 severe
- 95 moderate
- 12 info
Most severe, free to view
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- DolasetronA04AA04severe
- PalonosetronA04AA05severe
2 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under N02AD01
Pentazocine, as other registers publish it.
- FinlandDolapentOrion Corporation Orion Pharma
- BelgiumFortal 30 mg/mlSanofi Belgium
- BelgiumFortal 50 mgSanofi Belgium
- BelgiumFortal 50 mgSanofi Belgium
- United KingdomFortral 25mg tabletsZentiva Pharma UK Ltd
- United KingdomFortral 30mg/1ml solution for injection ampoulesZentiva Pharma UK Ltd
- United KingdomFortral 50mg suppositoriesSterwin Medicines
- United KingdomFortral 60mg/2ml solution for injection ampoulesZentiva Pharma UK Ltd
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dd0c5c18-21cc-4e36-bb7d-707c31b9b9d2 GET /v1/drugs/dd0c5c18-21cc-4e36-bb7d-707c31b9b9d2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "３０ｍｇ１管",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "1149401A2023",
"category": "注射薬",
"price_yen": 171,
"generic_name": "ペンタゾシン",
"product_name_jp": null,
"therapeutic_class": "1149",
"transitional_expiry": null
}See everything about pentazocine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.